Y
Yoni Heisler
Guest
Following widespread condemnation, Turing Pharmaceuticals CEO Martin Shkreli on Tuesday night announced that he would make the AIDS drug Daraprim more affordable than the originally planned $750 per pill price point that elicited so much outrage earlier this week.
"There were mistakes made with respect to helping people understand why we took this action," Shkreli told NBC News. "I think that it makes sense to lower the price in response to the anger that was felt by people."
While Shkreli hasn't yet disclosed what the new price will be, he said that a final decision will be made sometime in the next few weeks. Now given some of the information that's come to light about Shkreli's previous antics, one can only hope that he isn't simply trying to bide his time in the hopes that the story will blow over, only to announce a negligible reduction in price once the fast-moving news cycle has moved on to other issues.
Continue reading...
Via BRG - Boy Genius Report